Hong Kong’s ban on cannabidiol (CBD) comes into effect on February 1, imposing harsh penalties for importing, producing, or possessing the substance.
CBD will be subject to the same strict controls as other drugs listed under the Dangerous Drugs Ordinance (DDO).
The importation of goods containing the component, including food and beverages, is forbidden, according to Hong Kong's customs administration, unless pertinent DDO rules are followed.
Au-Yeung Ka-lun, a customs intelligence officer, stated that CBD will be treated as a dangerous narcotic and will be governed by the Dangerous Drugs Ordinance.
The maximum punishment for importing, exporting, and producing CBD is a HKD 5 million fine and a life sentence. The maximum penalty for possession is seven years in prison and a fine of up to HKD 1 million.
By the end of the month, all items containing the component were to be put in trash boxes erected throughout the city, according to a government directive. Approximately 77,400 CBD-containing products, including dietary supplements and edible oils, have been gathered as of January 29.


Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
U.S. Stock Futures Edge Higher as Tech Rout Deepens on AI Concerns and Earnings
US Judge Rejects $2.36B Penalty Bid Against Google in Privacy Data Case
Federal Judge Blocks Trump Administration Move to End TPS for Haitian Immigrants
Dollar Steadies Ahead of ECB and BoE Decisions as Markets Turn Risk-Off
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 



